carboplatin-gemcitabine-bevacizumab: expanding treatment options for recurrent platinum sensitive...
Published 6 months ago • 10 plays • Length 13:06Download video MP4
Download video MP3
Similar videos
-
3:35
asco highlights: bevacizumab for relapsed ovarian cancer
-
5:41
bevacizumab’s role in recurrent ovarian cancer
-
6:57
bevacizumab in platinum-resistant ovarian cancer
-
3:21
asco: targeted agent slows recurrent ovarian cancer
-
1:19
relacorilant nab-paclitaxel in recurrent, platinum-resistant ovarian cancer
-
1:45
dr. sikov on bevacizumab or carboplatin impact on tnbc subtype
-
16:40
adjuvant pembrolizumab for high-risk, dmmr endometrial cancer
-
2:26
asco: pembrolizumab for recurrent ovarian cancer
-
5:06
asco22 gynecologic oncology: relacorilant combined with nab-paclitaxel in recurrent ovarian cancer
-
4:12
calgb 90601: comparing gemcitabine and cisplatin with bevacizumab to placebo for metastatic urot...
-
3:18
asco: new hope for platinum-resistant ovarian cancer
-
14:46
managing platinum-resistant ovarian cancer
-
6:51
jco po article insights: talazoparib in solid tumors with brca1/2 mutation
-
0:55
dr. karasic on palbociclib in esophageal and gastric cancer
-
0:49
dr. bang on pembrolizumab for advanced gastric cancer
-
4:23
safety and tolerability of avb500 in platinum-resistant recurrent ovarian cancer
-
0:59
asco 2012 - avastin for platinum-resistant ovarian cancer / hipocrate journal romania
-
3:29
rucaparib boosts pfs in brca-mutated recurrent ovarian cancer